Peter Wijngaard

Nessuna posizione attualmente

Patrimonio netto: 1 531 $ in data 30/06/2024

61 anni

34 relazioni

Health Technology

Consumer Services

Storia della carriera di Peter Wijngaard

Precedenti posizioni note di Peter Wijngaard

Società	Posizione	Inizio	Fine
HEPION PHARMACEUTICALS, INC.	Direttore/Membro del Consiglio	10/06/2020	04/12/2023
HEPION PHARMACEUTICALS, INC.	Independent Dir/Board Member	10/06/2020	04/12/2023
The Medicines Company (Schweiz) GmbH	Corporate Officer/Principal	-	01/01/2020
Ciclofilin Pharmaceuticals, Inc. Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA.	Direttore/Membro del Consiglio	01/03/2014	01/06/2016
Isotechnika Pharma, Inc. Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.	Direttore/Membro del Consiglio	01/02/2011	23/10/2013
	Independent Dir/Board Member	01/02/2011	23/10/2013
Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.	Direttore/Membro del Consiglio	-	-
AURINIA PHARMACEUTICALS INC.	Direttore/Membro del Consiglio	25/10/2013	-
	Presidente	18/02/2011	25/10/2013
	Independent Dir/Board Member	18/02/2011	-

Formazione di Peter Wijngaard

University of Utrecht

Doctorate Degree

Statistiche

Distribuzione geografica

Stati Uniti	4
Canada	3
Paesi Bassi	2

Posizioni

Director/Board Member	5
Independent Dir/Board Member	3
Doctorate Degree	1

Settori

Health Technology	6
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa	2
AURINIA PHARMACEUTICALS INC.	Health Technology
HEPION PHARMACEUTICALS, INC.	Health Technology

Aziende private	4
Isotechnika Pharma, Inc. Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.	Health Technology
The Medicines Company (Schweiz) GmbH
Ciclofilin Pharmaceuticals, Inc. Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA.	Health Technology
Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.	Health Technology

Vedi le connessioni aziendali